Score Breakdown
Trash.
IonQ is a speculative quantum computing platform with impressive revenue growth but deeply concerning fundamentals. SBC alone is 200% of revenue, annual dilution is 62%, and the company burns cash at an extraordinary rate. Revenue quality is suspect—66% unbilled receivables, cost-to-cost POC recognition, and allegations of government earmark dependency. The $17.5B market cap implies a 93x P/S ratio on a company that may not achieve positive FCF for 5+ years, by which time dilution will have destroyed per-share value. The SkyWater acquisition adds manufacturing complexity and goodwill impairment risk. While the $3.1B cash position prevents near-term insolvency, the path to profitability requires quantum computing to achieve commercial utility at scale—a milestone no company has yet demonstrated. At current valuation, almost everything must go right, and the 23.5% short interest reflects justified skepticism.
Negative cash flow. Can't value it.
Some yellow flags.
Shares melting fast.
Neutral.
Plenty of cash.
Heavy bearish bets.
Below average.
🐻 Why Bears Hate It
The core of the bear case rests on the 'revenue illusion.' Critics argue that IonQ's growth is artificial, driven by 'backdoor earmarks' from friendly politicians rather than competitive technical wins. With these funding sources allegedly drying up in the FY 2026 budget, IonQ faces a projected $54 million revenue 'black hole.' Additionally, management's decision to stop reporting the 'bookings' metric under new CEO Niccolo de Masi is seen as an attempt to mask a deteriorating pipeline. The company’s widening losses—with 2026 adjusted EBITDA losses expected to hit $330 million—suggest a cash-burn trajectory that the current business cannot sustain without constant capital raises.
🔍 What's In The SEC Filings
While the administrative filing appears clean, the primary forensic risk is the structural dilution overhang from outstanding warrants at a fixed exercise price.
Substantial Warrant Overhang
“Warrants, each exercisable for one share of common stock for $11.50 per share”
The presence of $11.50 exercise price warrants suggests a future influx of shares that will dilute current equity holders if the stock appreciates beyond this strike price.
Dual-Listed Securities Risk
“Trading Symbol: IONQ WS”
The active listing of warrants on the NYSE alongside common stock creates complex volatility dynamics and arbitrage opportunities that can disadvantage long-term retail holders.
Valuation should be adjusted for a fully diluted share count including all exercisable warrants to avoid overestimating earnings per share.
The provided data is limited to a cover sheet, preventing a forensic analysis of the actual cash burn, R&D capitalization, or revenue recognition policies for Q1 2026.